95 results
Page 2 of 5
6-K
EX-99.5
ahnnijhhr ehb
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.4
b1whfg6zj16ul
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
ta0 475zy2d5ougz
18 Aug 21
Current report (foreign)
12:20pm
20-F/A
c4s rljq7ye3g6939v
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
f4jcrduua tuy45qffal
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
2e2txyf5uwy9myxft9yr
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
zteth2255 os3vyk
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
8e30d286g a9sqjx6m9
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm
6-K
EX-99.1
e3drwnfm5v8idohy
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.1
h5b7 r4wmf
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
iu0 5160jxes7
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
bu1i9y iw3
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
0lf5imbrlv567azvfi
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
tk7zmtybw1i93ty8q5
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
fdd 6mn7xrpsq62zrg
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
qorerd
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm